The Neuro’s drug discovery initiative supports research by developing assays shared with the scientific community
In the past 40 years, the model of drug discovery used by the pharmaceutical industry, while proving successful for some applications, has produced very little for neurodegenerative diseases.
“We have to ask if there is a better way to find therapies that will modify the course of diseases, slowing or stopping them from progressing. While Open Science is not going to solve every problem, it will be a big part of the solution.”“Take Parkinson’s disease, for instance: there have been zero new disease modifying medications developed in the last 40 years, despite hundreds of millions of dollars being invested in research,” says Dr. Edward Fon, whose lab focuses on molecular and cellular research into Parkinson’s disease. “We have to ask if there is a better way to find therapies that will modify the course of diseases, slowing or stopping them from progressing. While Open Science is not going to solve every problem, it will be a big part of the solution.”
The Neuro’s drug discovery initiative aims to support research by developing assays that investigate different aspects of target cells and sharing these assays with colleagues around the world. The main vehicle for sharing assays is The Neuro’s Induced Pluripotent Stem Cell (iPSC) platform, developed recently with seed money generously donated by Sebastian van Berkom and Ghislaine Saucier.
“We can provide industry-standard assays researchers can use to test compounds,” says Thomas Durcan, another Parkinson’s researcher who manages the iPSC platform. “In collaboration with researchers at Université Laval, we reprogram blood cells from patients with neurological diseases into stem cells, and then transform the stem cells into the type of neural cells most impacted in neuropathology.”
This gives researchers the ability to compare normal and diseased states of the cells within one patient, which has long been possible for some diseases but is a novel advance for neurological research. The Centre for Drug Research and Development, a Canadian nonprofit organization that aims to speed the translation of discoveries into therapies, and the international Structural Genomics Consortium have both formed partnerships with the Tanenbaum Open Science Institute to use the iPSC platform.
“If we can identify potential compounds for targeting diseases such as Parkinson’s and share them so they can be screened and tested throughout the scientific community, we can accelerate the rate of discovery,” says Dr. Fon. “Other researchers can benefit from the resources we develop, and the chances of 100 laboratories finding something useful is much greater than that of one lab working alone. If we can come up with something leading to treatment for Parkinson’s disease, that would be an incredible payback.”
Learn more: Accelerating drug discovery with Open Science
The Latest on: Open Science
via Google News
The Latest on: Open Science
- Completely open science has many potential consequenceson March 11, 2020 at 2:11 pm
A laboratory technician with the Home Team Science and Technology Agency (HTX) holds a VereChip Lab-on-Chip, part of the covid-19 test kits, at the CBRNE Laboratory in Singapore on Thursday. (Wei Leng ...
- Publisher Correction: Open Science principles for accelerating trait-based science across the Tree of Lifeon March 9, 2020 at 11:36 am
Correction to: Nature Ecology & Evolution https://doi.org/10.1038/s41559-020-1109-6, published online 17 February 2020.
- Diversity and Inclusion Are the Uniting Principle of Open Scienceon March 6, 2020 at 3:05 am
The only thing that links all varying strands of open science (and open scholarship more generally) is inclusion and diversity as a first principle. The primary value proposition of open science ...
- Column: COVID-19 could kill the for-profit science publishing model. That would be a good thingon March 3, 2020 at 4:41 pm
The critics support an “open access” model ... derailing of an expected initiative from the White House Office of Science and Technology Policy to make federally funded research immediately ...
- Roadmap for Open Science to reduce barriers and speed up discoveryon February 26, 2020 at 4:32 pm
The Government of Canada can now bolster its efforts in making federal science open and accessible to all thanks to the Roadmap for Open Science -- a set of ten recommendations delivered by Canada ...
- Roadmap for Open Science to reduce barriers and speed up discoveryon February 26, 2020 at 10:45 am
Canada's Chief Science Advisor delivers recommendations to make Canadian science open and accessible OTTAWA, Feb. 26, 2020 /CNW/ - Every day, Canadian researchers are coming up with new ideas with ...
- How service design can promote an “open science” solution for virus outbreakson February 26, 2020 at 8:34 am
At a rate not seen before, this is increasingly being done through “open science”, and a worldwide collaborative platform between scientists is championing this approach. Based dually between Basel ...
- Myanmar to be 1st country in ASEAN Region to launch free and open national research portalon February 25, 2020 at 8:19 am
"National Institute of Informatics (NII) has been developing a new repository software named WEKO3 in Research Center for Open Science and Data Platform (RCOS). It is based on the open repository ...
- White House formally invites public comment on open-access policieson February 21, 2020 at 11:25 am
"Dr. Droegemeier & @WHOSTP staff met with academic groups to discuss open science & public access. We are exploring opportunities to make the products of federally funded research more accessible.
via Bing News